Skip to main content
Equibles

HORIZON KINETICS ASSET MANAGEMENT LLC

Position in GALT — Galectin Therapeutics Inc

CIK 1056823 NEW YORK, NY
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$217,931
+$80,591 QoQ
Shares Held
46,968
-4.6% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 98 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HORIZON KINETICS ASSET MANAGEMENT LLC holds $23,045,365 across 14 Biotechnology names. GALT ranks #7 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 344,861 $19,336,356
2 IONS
Ionis Pharmaceuticals Inc
 10,904 $864,578
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,168 $652,633
4 CRSP
CRISPR Therapeutics AG
 9,353 $510,112
5 REGN
Regeneron Pharmaceuticals, Inc.
 645 $402,183
6 BEAM
Beam Therapeutics Inc.
 8,388 $287,876
7 GALT
Galectin Therapeutics Inc
This page 		46,968 $217,931
8 NTLA
Intellia Therapeutics, Inc.
 12,584 $212,921

All Filings in GALT

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $217,931 46,968
2026-03-31 $137,340 49,226
2025-12-31 $214,173 51,484
2025-09-30 $227,866 53,742
2025-06-30 $108,631 51,484
2025-03-31 $65,565 53,742
2024-12-31 $69,327 53,742
2024-09-30 $141,581 51,484
2024-06-30 $121,456 53,742
2024-03-31 $128,443 53,742
2023-12-31 $89,211 53,742
2023-09-30 $107,520 56,000
2023-06-30 $80,640 56,000
2023-03-31 $117,600 56,000
2022-12-31 $29,380 26,000
2022-09-30 $42,380 26,000
2022-06-30 $34,060 26,000
2022-03-31 $41,860 26,000
2021-12-31 $49,680 24,000
2021-09-30 $93,120 24,000
2021-06-30 $76,800 24,000